SEC Suspends Trading of Charming Medical Limited Securities

SEC: Trading Suspensions

Filed November 11th, 2025

Detected March 14th, 2026

Summary

The SEC has suspended trading of Charming Medical Limited (MCTA) securities for two weeks due to concerns of potential manipulation through social media recommendations. The suspension aims to protect investors from artificially inflated prices and trading volumes.

View original document View source feed page

What changed

The Securities and Exchange Commission (SEC) has ordered a temporary suspension of trading for Charming Medical Limited (MCTA) securities. This action, effective from November 12, 2025, through November 25, 2025, is a result of suspected market manipulation involving social media recommendations designed to artificially inflate the stock's price and trading volume. The company is incorporated in the British Virgin Islands and listed on the Nasdaq Capital Market.

This suspension directly impacts investors and the market's ability to trade MCTA securities during the specified period. The SEC's action highlights the risks associated with social media-driven investment recommendations and underscores the agency's commitment to maintaining market integrity. Regulated entities and investors should be aware of the potential for similar enforcement actions in cases of suspected manipulation.

What to do next

Monitor SEC enforcement actions related to market manipulation
Review internal controls for potential exposure to social media-driven trading schemes

Penalties

Trading suspension for 14 days

Source document (simplified)

UNITED STATES OF AMERICA Before the SECURITIES AND EXCHANGE COMMISSION SECURITIES EXCHANGE ACT OF 1934 Release No. 104176 / November 11, 2025 ____________________________________ IN THE MATTER OF : CHARMING MEDICAL : ORDER OF SUSPENSION LIMITED : OF TRADING ____________________________________ It appears to the Securities and Exchange Commission that the public interest and the protection of investors require a suspension in the trading of the securities of Charming Medical Limited (“MCTA”) (CIK No. 0002035992), a holding company incorporated in the British Virgin Islands and headquartered in Hong Kong, because of potential manipulation in the securities of MCTA effectuated through recommendations made to investors by unknown persons via social media to purchase, hold, and/or sell the securities of MCTA and to send screenshots documenting their transaction, which appear to be designed to artificially inflate the price and trading volume of the securities of MCTA. As of November 10, 2025, the common stock of MCTA is listed on the Nasdaq Capital Market under the symbol “MCTA.” The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed company.

THEREFORE, IT IS ORDERED, pursuant to Section 12(k) of the Exchange Act, that trading in the securities of the above-listed company is suspended for the period from 4:00 AM ET on November 12, 2025, through 11:59 PM ET on November 25, 2025. By the Commission. Vanessa A. Countryman Secretary